Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-14 Sale | 2024-10-15 8:06 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 8,053 | $11.11 | $89,450 | 2,400,455 (Indirect Direct) | View |
| 2024-07-12 Sale | 2024-07-15 6:32 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 8,053 | $12.53 | $100,904 | 2,407,194 (Indirect Direct) | View |
| 2024-04-12 Sale | 2024-04-16 5:15 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 8,360 | $14.58 | $121,889 | 2,415,247 (Indirect Direct) | View |
| 2024-03-18 Sale | 2024-03-19 9:46 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 28,583 | $15.82 | $452,183 | 2,423,607 (Indirect Direct) | View |
| 2024-03-14 Sale | 2024-03-15 8:05 pm | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 32,323 | $69.84 | $2,257,449 | 167,668 (Indirect Direct) | View |
| 2023-12-14 Purchase | 2023-12-18 5:02 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 139,665 | $7.16 | $1,000,001 | 2,229,067 (Indirect Direct) | View |
| 2022-09-06 Purchase | 2022-09-07 8:14 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 43,820 | $5.568 | $243,990 | 1,748,089 (Indirect Direct) | View |
| 2022-08-31 Purchase | 2022-09-01 8:36 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 993 | $4.9045 | $4,870 | 1,704,269 (Indirect Direct) | View |
| 2022-05-24 Purchase | 2022-05-25 7:27 pm | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 28,000 | $3.529 | $98,812 | 1,703,276 (Indirect Direct) | View |
| 2021-11-19 Purchase | 2021-11-23 07:30 am | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 3,950 | $37.3 | $147,350 | 167,668 (Indirect Direct) | View |
| 2021-04-13 Purchase | 2021-04-15 09:22 am | Liquidia Corp | LQDA | JEFFS ROGER Director | 99,206 | $2.52 | $249,999 | 1,505,301 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-07 Option Award | 2024-06-11 4:31 pm | 2025-06-07 2034-06-07 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 5,799 | $0 | 5,799 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 16,976 | $25.53 | 167,668 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,347 | $29.91 | 167,668 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | 2020-06-07 2029-06-07 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 32,323 | $0 | 167,668 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:05 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $22.03 | 167,668 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:34 pm | 2024-02-27 2034-02-26 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 1,425 | $0 | 1,425 (Direct) | View |
| 2024-01-11 Option Award | 2024-01-16 5:00 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 221,338 | $0 | 2,671,743 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 6:22 pm | 2024-06-02 2033-06-02 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 5,681 | $0 | 5,681 (Direct) | View |
| 2022-08-31 Option Award(A) | 2023-04-10 4:32 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 993 | $4.9045 | 1,704,269 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:13 pm | 2023-03-02 2033-03-01 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,082 | $0 | 2,082 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-13 5:17 pm | N/A 2033-01-11 | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 660,654 | $0 | 2,456,165 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-05 5:35 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 15,807 | $0 | 1,795,511 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-04 4:25 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 47,423 | $0 | 1,811,319 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:34 pm | 2026-01-03 2032-06-17 | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 931,475 | $0 | 931,475 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:07 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-20 4:35 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 154,167 | $0 | 1,659,468 (Indirect) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,347 | $0 | 2,347 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 5:05 pm | 2026-01-03 2032-01-03 | Liquidia Corp | LQDA | JEFFS ROGER Chief Executive Officer | 1,746,057 | $0 | 1,826,410 (Direct) | View |
| 2021-08-20 Option Award | 2021-09-01 5:25 pm | 2024-08-20 2031-08-20 | Liquidia Corp | LQDA | JEFFS ROGER Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 4:05 pm | N/A 2031-06-23 | ALBIREO PHARMA INC. | ALBO | JEFFS ROGER Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:52 pm | 2022-06-04 2031-06-04 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 7,325 | $0 | 7,325 (Direct) | View |
| 2021-03-24 Option Award | 2021-03-26 4:06 pm | N/A 2031-03-24 | Liquidia Corp | LQDA | JEFFS ROGER Director | 30,353 | $0 | 30,353 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:45 pm | 2021-03-05 2031-03-04 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 1,463 | $0 | 1,463 (Direct) | View |
| 2020-11-18 Other | 2020-11-19 4:11 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Director | 1,387,500 | $6 | 2,823,595 (Indirect) | View |
| 2020-11-18 Option Award | 2020-11-19 4:11 pm | N/A 2030-11-18 | Liquidia Corp | LQDA | JEFFS ROGER Director | 30,000 | $0 | 2,823,595 (Direct) | View |
Ownership | 2020-11-19 4:06 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Director | 0 | $0 | 18,595 (Direct) | View |
| 2020-06-19 Option Award | 2020-06-19 6:09 pm | N/A 2030-06-18 | ALBIREO PHARMA INC. | ALBO | JEFFS ROGER Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-05 6:41 pm | 2021-06-05 2030-06-05 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 9:18 pm | 2020-03-17 2030-03-16 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 4,496 | $0 | 4,496 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 5,193 | $8.02 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 9,127 | $9 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 11,000 | $4.95 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 34,866 | $12.95 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | 2016-11-19 2025-11-18 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 60,186 | $0 | 163,718 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:36 pm | N/A 2027-05-24 | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 109,993 | $0 | 0 (Direct) | View |